Navigation Links
First Warning Systems Receives Investment by Members of the Reno Angels and Local Investors

RENO, Nev., Aug. 6, 2012 /PRNewswire/ -- First Warning Systems, Inc. announces members of the Reno Angels have joined together with local investors to invest in the First Warning Systems $1,000,000 Series A funding round. 

Jim Holmes, First Warning's CEO states, "We are approaching fifty percent completion of this Series A round of financing.  We appreciate members of the Reno Angels and local investors' support of the First Warning System." 

For particulars concerning the Series A round, please check First Warning's website:

The First Warning patented technology uses predictive analytics software to penetrate imaging technology barriers that are limited to viewing a tumor that, on average, has been growing for 11 years.  Deep tissue temperature analysis from 12 hours of dynamic data collection is modeled using predictive analytics software to compare circadian body rhythms that can identify abnormalities up to 6 years prior to imaging technologies. The First Warning product vision video can be seen at

Holmes adds, "We are planning the establishment of a production facility for our products, determining employee requirements to support worldwide marketing and sales.  We are investigating and hopeful of being able to establish these operations in the Truckee Meadows area."        

About First Warning Systems

First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS' principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO). FWS holds the exclusive worldwide license from Lifeline Biotechnologies for development, manufacturing and marketing of the software-based technologies. The FWS product line is a patented device and process that detects breast tissue abnormalities for health risk assessment and management earlier than any other known modalities.  These tissue abnormalities can lead to breast cancers. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes with industry leading 90% accuracy.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS predictive analytics product.  FWS is preparing for Euro CE Mark and marketing in the UK, EU and Russian markets.  For more information check

For more information, contact: Jim Holmes, CEO 775-324-3822 or 775-852-3222, 

SOURCE First Warning Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
2. Midwest Health Care Startups Raise $511 Million in First Half of 2012
3. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
4. Target for potent first-strike influenza drugs identified
5. Genelex Receives First Patent on Business Methods for Pharmacogenetics
6. TI introduces the industrys first weigh scale and body composition analog front end
7. Midwest Health Care Startups Raise $491 Million in First Half of 2012
8. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
9. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
10. AHIMA Launches First HIM Career Map
11. MIOT Hospital Delivers First TrueBeam STx Radiotherapy Treatment in Chennai
Post Your Comments:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):